This record was last updated January 13, 2026 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Post-marketing study investigating the impact of frequant usage with Nerivio on the safety profile of Remote Electrical Neuromodulation (REN) for the treatment of migraine.
This study assessed the safety and tolerability of REN when used at frequencies exceeding the labeled indication.